Zelluna ASA
Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.
ULTI | OL
Overview
Corporate Details
- ISIN(s):
- NO0010851603
- LEI:
- 254900B4VALJZR9TL744
- Country:
- Norway
- Address:
- Ullernchausseen 64, 0379 Oslo
- Website:
- https://www.zelluna.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Zelluna ASA is a clinical-stage biopharmaceutical company focused on developing treatments for solid cancers. The company is pioneering a proprietary, allogeneic T-cell receptor-based Natural Killer (TCR-NK) cell therapy platform. This "off-the-shelf" approach merges the targeting capabilities of T-cell receptors with the therapeutic functions of NK cells to address significant unmet medical needs in oncology. Zelluna's mission is to deliver transformative, safe, and cost-efficient therapies with the potential to cure patients with advanced solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-04 13:04 |
Pre-Annual General Meeting Information
Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025 - Atta…
|
Norwegian | 1014.6 KB | ||
| 2025-11-04 13:04 |
Pre-Annual General Meeting Information
Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025
|
English | 1.4 KB | ||
| 2025-11-04 09:10 |
Major Shareholding Notification
Zelluna ASA: Disclosure of large shareholding
|
English | 986 bytes | ||
| 2025-11-04 08:28 |
Major Shareholding Notification
Zelluna ASA: Disclosure of large shareholding
|
English | 1.2 KB | ||
| 2025-11-04 07:29 |
Major Shareholding Notification
Zelluna ASA: Disclosure of large shareholding
|
English | 2.1 KB | ||
| 2025-11-04 07:00 |
Share Issue/Capital Change
Zelluna ASA - Ex. date
|
English | 550 bytes | ||
| 2025-11-04 00:58 |
Share Issue/Capital Change
Zelluna ASA - Key information relating to subsequent offering
|
English | 2.8 KB | ||
| 2025-11-04 00:35 |
Share Issue/Capital Change
Zelluna ASA - Mandatory notification of trade - Attachment: 20251104 - PDMR att…
|
English | 219.0 KB | ||
| 2025-11-04 00:35 |
Director's Dealing
Zelluna ASA - Mandatory notification of trade
|
English | 703 bytes | ||
| 2025-11-03 23:52 |
Investor Presentation
Zelluna ASA - Successful private placement and retail offering - Attachment: Ze…
|
English | 993.4 KB | ||
| 2025-11-03 23:52 |
Share Issue/Capital Change
Zelluna ASA - Successful private placement and retail offering
|
English | 21.0 KB | ||
| 2025-11-03 16:47 |
Share Issue/Capital Change
Zelluna ASA - Contemplates private placement
|
English | 22.8 KB | ||
| 2025-11-03 16:39 |
Quarterly Report
Zelluna ASA Reports Third Quarter 2025 Financial Results and Provides General B…
|
English | 855.0 KB | ||
| 2025-11-03 16:39 |
Earnings Release
Zelluna ASA Reports Third Quarter 2025 Financial Results and Provides General B…
|
English | 6.4 KB | ||
| 2025-10-09 07:58 |
Legal Proceedings Report
Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy fo…
|
English | 5.2 KB |
Automate Your Workflow. Get a real-time feed of all Zelluna ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Zelluna ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Zelluna ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
